Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1998

Study Completion Date

September 30, 2002

Conditions
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
Interventions
DRUG

allovectin-7

DRUG

allovectin-7/dacarbazine

DRUG

dacarbazine

Trial Locations (44)

10003

Beth Israel Medical Center, New York

10029

Mount Sinai School of Medicine, New York

11021

Arena Oncology Associates, Great Neck

11235

HemOnCare, P.C., Brooklyn

20010

Washington Cancer Institute, Washington D.C.

21237

Franklin Square Hospital Center, Baltimore

23704

Cancer Treatment Centers of America in Hampton Roads, Portsmouth

24541

Danville Hematology and Oncology, Inc., Danville

29605

Cancer Centers of the Carolinas, Greenville

30033

Georgia Cancer Specialists, Decatur

30344

Georgia Cancer Specialists, P.C., East Point

33140

Mount Sinai Comprehensive Cancer Center, Miami Beach

43222

Mid-Ohio Oncology/Hematology, Inc., Columbus

43623

Toledo Clinic, Inc., Toledo

47150

Cancer Care Center, New Albany

47403

Cancer Care Center for Southern Indiana, Bloomington

48075

Providence Hospital Cancer Center, Southfield

53226

Medical College of Wisconsin, Milwaukee

55407

Virginia Piper Cancer Institute, Minneapolis

55416

Park Nicollet Clinic, Saint Louis Park

55422

North Memorial Health Care, Robbinsdale

55905

Mayo Clinic Cancer Center, Rochester

58501

Mid Dakota Clinic, P.C., Bismarck

59101

Billings Interhospital Oncology Project, Billings

60068

Lutheran General Hospital, Park Ridge

63131

Missouri Baptist Cancer Center, St Louis

66205

Oncology and Hematology Associates, Westwood

68124

Bergan Mercy Medical Center, Omaha

72205

University of Arkansas for Medical Sciences, Little Rock

84112

Huntsman Cancer Institute, Salt Lake City

92023

Scripps Memorial Hospitals-Stevens Cancer Center - Encinitas, Encinitas

92120

Kaiser Permanente-Southern California Permanente Medical Group, San Diego

93309

Comprehensive Blood and Cancer Center, Bakersfield

96817

St. Francis Medical Center, Honolulu

98109

Seattle Cancer Care Alliance, Seattle

06520-8028

Yale Comprehensive Cancer Center, New Haven

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

40536-0093

Lucille Parker Markey Cancer Center, University of Kentucky, Lexington

70112-2822

Louisiana State University School of Medicine, New Orleans

63110-0250

St. Louis University Health Sciences Center, St Louis

03756-0002

Norris Cotton Cancer Center, Lebanon

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

19104-4283

University of Pennsylvania Cancer Center, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Vical

INDUSTRY

NCT00003647 - Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma | Biotech Hunter | Biotech Hunter